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We report a case of luteinizing thecoma in a 58-year-old postmenopausal woman who presented with progressive androgenic
features and hypertension of one year duration. She did not notice a signiﬁcant change in her body weight or appetite. Her
total serum testosterone level was 4.5ng/mL. Ultrasound scan revealed a normal-sized uterus and a right-sided solid ovarian
mass of 5cm × 5cm. Left ovary was normal. She had a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and
an omentectomy performed. Histological examination conﬁrmed the diagnosis of luteinized thecoma. This case illustrates the
necessity to consider the rare possibility of luteinized ovarian thecoma as a cause for virilization in a menopausal woman.
Copyright © 2009 Athula Kaluarachchi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Virilization due to hyperandrogenism caused by a luteinized
thecoma in a postmenopausal woman is extremely rare.
2.CaseReport
A 58-year-old postmenopausal woman of two living children
presented to the university gynecological unit, National Hos-
pital of Sri Lanka, Colombo, complaining of progressive hair
loss and male-type hair distribution of one year duration.
These symptoms were accompanied by lower abdominal
pain for the last four months duration. She did not notice a
signiﬁcant change in her body weight or appetite. There was
no postmenopausal bleeding or vaginal discharge.
She was diagnosed to have hypertension for the last
one and half year duration and was on regular treatment
with a good control of blood pressure. She had undergone
hemithyroidectomy at the age of 44 years due to a cold
nodule. Histology had revealed a follicular adenoma and she
was treated with L-thyroxine 50µgd a i l y .
On examination, she had alopecia, frontal balding, and
hirsuitism involving the face, chin, upper back, chest, upper
and the lower abdomen giving a score of 14 from modiﬁed
Ferriman and Gallwey scoring system (Figure 1(a)).
She had clitoromegally. Her respiratory and cardiovas-
cular systems were normal. Pelvic examination revealed a
solid right ovarian mass of 5cm size and it was conﬁrmed
by pelvic ultrasound scan. It was a solid mass with an
intact capsule. The uterus and the other ovary were normal
and there was no free ﬂuid. Liver and the other abdominal
organs were normal. Computed tomography (CT-scan) of
the abdomen and pelvis revealed a well-deﬁned solid tumor
of 5.5×3×6cm in right adnexal region (Figure 1(b)). Other
pelvic structuresand the suprarenalglands werenormal. Her
investigation results were as in Figure 2.
Laparotomy revealed a solid ovarian tumor of 5cm with
an intact capsule in the right ovary. The left ovary and the
uterus were normal (Figure 1(c)). There was no free ﬂuid.
There were no intraperitoneal deposits. Total abdominal
hysterectomy and bilateral salpingo-oophorectomy along





Figure 1: (a) On examination, she had alopecia, frontal balding, and hirsuitism giving a score of 14 from modiﬁed Ferriman and Gallwey
scoring system. (b) Computed tomography of the abdomen and pelvis revealed a well-deﬁned solid tumor in right adnexal region (arrow).
(c) Laparotomy revealed a solid ovarian tumor of 5cm with an intact capsule in the right ovary. (d) Haematoxyline and eosine-stained
sections (magniﬁcation 10 × 100) revealed cell nets comprising uniform cells with round bland nuclei and eosinophilic cytoplasm. They
were surrounded by a proliferation of elongated spindle cells.
CA-125: 13 µg/mL. (Normal reference range: < 35 µg/mL)
FSH 21.8 µg/mL (postmenopausal >25). LH 5.5 µg/mL (postmenopausal >50).
Serum testosterone was 4.5 ng/mL (reference ranges–female–0.06–0.82 ng/mL
male–2.8–8.0 ng/mL)
Free testosterone 16.6 pg/mL (reference range Postmenopausal female–0.1–1.7 pg/mL
 male–5.5–42 pg/mL)
Dehydroepiandrosterone sulphate (DHEA) 138 µg/dL (reference range–female– 35–430)
TSH 1.8 mIU/L (reference range 0.5–5 mIU/L)
T4 14 µg/dL (reference range 4–12 µg/dL)
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an uneventful recovery and was discharged on the fourth
postoperative day.
Histological examination of sections from the right
ovarianmassstainedwithhaematoxylineandeosinerevealed
cell nets comprising uniform cells with round bland nuclei
and eosinophilic cytoplasm. Mitotic ﬁgures were sparse.
They were surrounded by a proliferation of elongated
spindle cells with bland nuclei (Figure 1(d)). A histological
diagnosis of luteinized thecoma was made. The capsule of
the mass was intact. The other ovary, uterus, cervix, and the
omentum were normal. The endometrium was nonreactive
with atrophic changes.
The patient was reviewed two months after the surgery.
Hirsuitism was still there, but there was regression of
virilism. Her serum testosterone was 0.09ng/mL (reference
ranges—female—0.06–0.82ng/mL) when she was reviewed
ten months after surgery and there was a signiﬁcant decrease
in both hirsuitism and virilism.
3. Discussion
Hyperandrogenism is one of the most common endocrine
disorders in women accounting for large number of visits
to the general practitioners and the gynecologists. Polycystic
ovary syndrome accounts for majority of them in the repro-
ductive aged women. Virilization due to hyperandrogenism
is rare in postmenopausal women. Hyperandrogenism due
to a luteinized thecoma in a postmenopausal woman is
extremely rare. Review of the indexed literature (MEDLINE
1966–2008, English language; search terms: luteinized the-
coma, Postmenopausal) revealed only a handful of cases of
luteinized thecoma in a postmenopausal patient who had
presented with virilization and alopecia [1]. There were few
other reported cases of ovarian thecoma in postmenopausal
woman, where the presenting symptoms were androgenic
manifestations, bleeding, and abdominal pain [2, 3]. The
histology of these patients did not reveal luteinization.
Ovarian thecoma is a rare hormonally active tumor
of stromal cell origin and represents less than 1% of all
o v a r i a nt u m o r s .I to c c u r sm o s to f t e ni np e r i m e n o p a u s a la n d
postmenopausal women [4]. Seventy percent of thecomas
secreteoestrogensandusuallypresentswithpostmenopausal
bleeding and with endometrial hyperplasia or malgnancy
[5]. Nevertheless, androgens and exceptionally progesterone
or corticosteroids are occasionally produced [6]. When the
tumor contains luteinized cells, which is observed in 10% of
thecomas [6], they secrete androgens and lead to virilization
which was observed in our patient. Typical picture of
androgen secretion is oligomenorrhoea, defeminization, and
progressive virilization (acne, hirsuitism, temporal balding,
enlargement of clitoris, deepening of the voice, and muscular
development). Our patient developed complete change of
the external appearance within a short period of time. This
change created a socially embarrassing situation which lim-
ited her social interaction as well as physical performances.
The diagnosis of a virilizing ovarian tumor is most often
complicated by the ﬁndings of clinical features suggestive
of Cushing’s syndrome. However, in our patient an adrenal
tumor and Cushing’s syndrome were excluded by ultrasound
scan, CT, of the abdomen and by biochemical tests.
Elevation of serum testosterone level above 2ng/mL has
been proposed as a signiﬁcant level which indicates the
presence of an androgen secreting tumor. Testosterone levels
in polycystic ovarian disease and stromal hyperthecosis are
often below this level. Serum testosterone level of 4.5ng/mL
in our patient was strongly indicative of the presence of an
androgen secreting ovarian tumor [7]. Size of most ovarian
thecomas ranges from 5–10cm and is bilateral in 3% of cases
[8]. Our patient had a unilateral tumor measuring about
5cm which was detected on ultrasound and CT-scan.
Surgical intervention is generally adopted as the pri-
mary mode of treatment. Owing to the postmenopausal
status of our patient, it was recommended to proceed
with total abdominal hysterectomy and bilateral salpingo-
oophorectomy as therapy for a presumed ovarian malig-
nancy. However, histology of the aﬀected ovary did not
reveal any possibility of malignancy. Serum testosterone
level returned to normal after surgery and the patient was
happy and contended when she was reviewed ten months
after surgery since there was signiﬁcant improvement in her
clinical status. This case illustrates the necessity to consider
the rare possibility of luteinized ovarian thecoma as a cause
for virilization in a menopausal woman.
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